Immunophenotype of blast cells in chronic myeloid leukemia. 1988

O Valiron, and G Clemancey-Marcille, and A Troesch, and A Schweitzer, and M Prenant, and D Hollard, and R Berthier
INSERM U217, Laboratoire d'Hématologie, Grenoble, France.

The immunophenotype of peripheral blood blast cells from 14 patients in the chronic phase of chronic myeloid leukemia (CML) was studied using a panel of monoclonal antibodies (McAb) directed against megakaryocytic, granulomonocytic, erythroid and lymphoid antigenic determinants. The blast cells were enriched by a simple bovine serum albumin (BSA) density-cut separation and cooled in liquid nitrogen. The study was done using the alkaline phosphatase-anti-alkaline phosphatase (APAAP) technique on the thawed blast cells. A consistent pattern of reactivity with McAb was found in all patients, showing that blast cells were heterogeneous. A minor component of the blast cells react with platelet antibodies, most of them being labelled with anti-GPIIb-IIIa McAb. Anti-GPIb and Von Willebrand factor McAb detected 4 times fewer megakaryocytic blast cells, suggesting that these cells are located very early in the differentiation scheme. Two major blast cell compartments were labelled with early myelomonocytic (anti-CD13: MY7) and early erythroid (anti-CD36: FA6-152) McAb. The CD34 (My10) and DR antigens which are expressed by immature blast cells and myeloid progenitors of human bone marrow (BM) were present on more than 50% of the CML blast cells. Thus, the blast cells of chronic phase CML patients, showed the same cellular diversity as the increased progenitor cell compartment observed in this disease, and their differentiation stages seemed to be very closely related.

UI MeSH Term Description Entries
D007937 Leukapheresis The preparation of leukocyte concentrates with the return of red cells and leukocyte-poor plasma to the donor. Leukocytapheresis,Leukopheresis,Lymphapheresis,Lymphocytapheresis,Leukocytopheresis,Lymphocytopheresis,Lymphopheresis,Leukaphereses,Leukocytaphereses,Leukocytophereses,Leukophereses,Lymphaphereses,Lymphocytaphereses,Lymphocytophereses,Lymphophereses
D010641 Phenotype The outward appearance of the individual. It is the product of interactions between genes, and between the GENOTYPE and the environment. Phenotypes
D001752 Blast Crisis An advanced phase of chronic myelogenous leukemia, characterized by a rapid increase in the proportion of immature white blood cells (blasts) in the blood and bone marrow to greater than 30%. Blast Phase,Blast Crises,Blast Phases,Crises, Blast,Crisis, Blast,Phase, Blast,Phases, Blast
D002469 Cell Separation Techniques for separating distinct populations of cells. Cell Isolation,Cell Segregation,Isolation, Cell,Cell Isolations,Cell Segregations,Cell Separations,Isolations, Cell,Segregation, Cell,Segregations, Cell,Separation, Cell,Separations, Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000911 Antibodies, Monoclonal Antibodies produced by a single clone of cells. Monoclonal Antibodies,Monoclonal Antibody,Antibody, Monoclonal
D000912 Antibodies, Neoplasm Immunoglobulins induced by antigens specific for tumors other than the normally occurring HISTOCOMPATIBILITY ANTIGENS. Neoplasm Antibodies,Tumor Antibodies,Antibodies, Tumor
D000943 Antigens, Differentiation Antigens expressed primarily on the membranes of living cells during sequential stages of maturation and differentiation. As immunologic markers they have high organ and tissue specificity and are useful as probes in studies of normal cell development as well as neoplastic transformation. Differentiation Antigen,Differentiation Antigens,Differentiation Antigens, Hairy Cell Leukemia,Differentiation Marker,Differentiation Markers,Leu Antigen,Leu Antigens,Marker Antigen,Marker Antigens,Markers, Differentiation,Antigen, Differentiation,Antigen, Leu,Antigen, Marker,Antigens, Leu,Antigens, Marker,Marker, Differentiation
D000951 Antigens, Neoplasm Proteins, glycoprotein, or lipoprotein moieties on surfaces of tumor cells that are usually identified by monoclonal antibodies. Many of these are of either embryonic or viral origin. Neoplasm Antigens,Tumor Antigen,Tumor Antigens,Antigen, Tumor,Antigens, Tumor
D014407 Tumor Cells, Cultured Cells grown in vitro from neoplastic tissue. If they can be established as a TUMOR CELL LINE, they can be propagated in cell culture indefinitely. Cultured Tumor Cells,Neoplastic Cells, Cultured,Cultured Neoplastic Cells,Cell, Cultured Neoplastic,Cell, Cultured Tumor,Cells, Cultured Neoplastic,Cells, Cultured Tumor,Cultured Neoplastic Cell,Cultured Tumor Cell,Neoplastic Cell, Cultured,Tumor Cell, Cultured

Related Publications

O Valiron, and G Clemancey-Marcille, and A Troesch, and A Schweitzer, and M Prenant, and D Hollard, and R Berthier
October 1998, Schweizerische medizinische Wochenschrift,
O Valiron, and G Clemancey-Marcille, and A Troesch, and A Schweitzer, and M Prenant, and D Hollard, and R Berthier
October 1995, Leukemia & lymphoma,
O Valiron, and G Clemancey-Marcille, and A Troesch, and A Schweitzer, and M Prenant, and D Hollard, and R Berthier
December 2016, Blood advances,
O Valiron, and G Clemancey-Marcille, and A Troesch, and A Schweitzer, and M Prenant, and D Hollard, and R Berthier
January 1983, Folia haematologica (Leipzig, Germany : 1928),
O Valiron, and G Clemancey-Marcille, and A Troesch, and A Schweitzer, and M Prenant, and D Hollard, and R Berthier
January 2023, Autopsy & case reports,
O Valiron, and G Clemancey-Marcille, and A Troesch, and A Schweitzer, and M Prenant, and D Hollard, and R Berthier
January 1990, Hematological oncology,
O Valiron, and G Clemancey-Marcille, and A Troesch, and A Schweitzer, and M Prenant, and D Hollard, and R Berthier
June 1987, American journal of hematology,
O Valiron, and G Clemancey-Marcille, and A Troesch, and A Schweitzer, and M Prenant, and D Hollard, and R Berthier
January 2014, European journal of haematology,
O Valiron, and G Clemancey-Marcille, and A Troesch, and A Schweitzer, and M Prenant, and D Hollard, and R Berthier
October 1998, Sangre,
O Valiron, and G Clemancey-Marcille, and A Troesch, and A Schweitzer, and M Prenant, and D Hollard, and R Berthier
January 1996, Leukemia research,
Copied contents to your clipboard!